Sex and critical illness

Current Opinion in Critical Care

Volumn 15, Issue 5, 2009, Pages 442-449

  Fowler, Robert A ^a   Filate, Woganee ^a   Hartleib, Michael ^b   Frost, David W ^a   Lazongas, Chris ^a   Hladunewich, Michelle ^a,c  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b Peterborough Regional Health Centre   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Acute lung injury; Critical care; Female; Intensive care; Male; Sepsis; Sex

Indexed keywords

ACUTE LUNG INJURY; CLINICAL RESEARCH; CRITICAL ILLNESS; HEALTH CARE DELIVERY; HOSPITAL ADMISSION; INTENSIVE CARE; PATIENT DECISION MAKING; REVIEW; SEPSIS; SEX DIFFERENCE;

ACUTE DISEASE; ACUTE LUNG INJURY; ANIMALS; CLINICAL TRIALS AS TOPIC; CRITICAL ILLNESS; DECISION MAKING; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; MALE; SEPSIS; SEX DISTRIBUTION; SEX FACTORS; TREATMENT OUTCOME;

EID: 70350106712     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e3283307a12     Document Type: Review

References (94)

1. Raine R, Goldfrad C, Rowen K, Black N. Influence of patient gender on admission to intensive care. J Epidemiol Commun Health 2002; 56:418-1418.
2. Joushilahti P, Vartiainen E, Tuomilehto J, Puska P. Sex, age, cardiovascular risk factors and coronary heart disease: a prospective follow-up study of 14786 middle-aged men and women in Finland. Circulation 1999; 99:1165-1172.
3. Jaglal S, Goel V, Naylor C. Sex differences in the use of invasive coronary procedures in Ontario. Can J Cardiol 1994; 10:239-244.
4. Rathore SS, Chen J, Wang Y, et al. Sex differences in cardiac catheterization: the role of physician gender. J Am Med Assoc 2001; 286:2849-2856.
5. Garrouste-Orgeas M, Montuclard L, Timsit J-F, et al. Predictors of intensive care unit refusal in French Intensive Care Units: a multicentre study. Crit Care Med 2005; 33:750-755.
6. Alter DA, Naylor CD, Austin PC, Tu JV. Biology or bias: practice patterns and long-term outcomes for men and women with acute myocardial infarction. J Am Coll Cardiol 2002; 39:1909-1916.
7. Alter DA, Naylor CD, Austin P, Tu JV. Effects of socioeconomic status on access to invasive cardiac procedures and on mortality after acute myocardial infarction. N Engl J Med 1999; 341:1359-1367.
8. Kapral MK, Wang H, Austin PC, et al. Ontario Carotid Endarterectomy Registry. Sex differences in carotid endarterectomy outcomes: results from the Ontario Carotid Endarterectomy Registry. Stroke 2003; 34:1120-1125.
9. Kapral MK, Wang H, Mamdani M, Tu JV. Effect of socioeconomic status on treatment and mortality after stroke. Stroke 2002; 33:268-273.
10. Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-1554.
11. Ayianian J, Epstein A. Differences in the use of procedures between women and men hospitalized for coronary heart disease. N Engl J Med 1991;325:221-225.
12. Vaccarino V, Parsons L, Every NR, et al. Sex-based differences in early mortality after myocardial infarction: National Registry of Myocardial Infarction participants. N Engl J Med 1999; 341:217-225.
13. Malacrida R, Genoni M, Maggioni AP, et al. A comparison of the early outcome of acute myocardial infarction in women and men: the Third International Study if Infarct Survival Collaborative Group. N Engl J Med 1998; 338:8-14.
14. Maynard C, Every NR, Martin JS, et al. Association of gender and survival in patients with acute myocardial infarction. Arch Intern Med 1997; 157:1379-1384. (Pubitemid 27264280)
15. Weaver WD, White HD, Wilcox RG, et al., GUSTO-I Investigators. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. J Am Med Assoc 1996; 275:777-782.
16. Valentin A, Jordan B, Lang T, et al. Gender-related differences in intensive care: a multiple-center cohort study of therapeutic interventions and outcome in critically ill patients. Crit Care Med 2003; 31:1901-1907.
17. Romo H, Amaral ACK-B, Vincent J-L. Effect of patient sex on intensive care unit survival. Arch Intern Med 2004; 164:61-65.
18. Fowler RA, Sabur N, Juurlink D, et al. Sex-based differences in the delivery and outcomes of critical care. CMAJ 2007; 177:1513-1519. Among patients 50 years or older, women appear less likely than men to be admitted to an ICU and to receive selected life-supporting treatments and more likely than men to die after critical illness. Differences in presentation of critical illness, decision-making or unmeasured confounding factors may contribute to these findings.
19. Phua J, Badia JR, Adhikari NK, et al. Has mortality from acute respiratory distress syndrome decreased over time? A systematic review. Am J Respir Crit Care Med 2009; 179:220-227.
20. Esteban A, Anzueto A, Frutos F, et al., for the Mechanical Ventilation International Study Group. Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day international study. J Am Med Assoc 2002; 287:345-355.
21. Needham DM, Bronskill SE, Sibbald WJ, et al. Mechanical ventilation in Ontario, 1992-2000: incidence, survival, and hospital bed utilization of noncardiac surgery adult patients. Crit Care Med 2004; 32:1504-1510.
22. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2000; 348:1546-1554.
23. Padkin A, Goldfrad C, Brady AR, et al. Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales and Northern Ireland. Crit Care Med 2003; 31:2332-2338.
24. Finfer S, Belloma R, Lipman J, et al. Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units. Intensive Care Med 2004; 30:589-596.
25. Brun-Buisson C, Doyon F, Carlet J, et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. J Am Med Assoc 1995; 274:968-974.
26. Anderson RN, Smith BL. Deaths: leading causes for 2001. Natl Vital Stat Rep 2003; 52:1-85.
27. Angus D, Linde-Zwirble W, Lidicker J. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome and associated costs of care. Crit Care Med 2001; 29:1303-1310.
28. Weycker D, Akhras KS, Edelsberg J, et al. Long-term mortality and medical care charges in patients with severe sepsis. Crit Care Med 2003; 31:2216-2223.
29. Hartlieb MC, Fowler RA, Hladunewich M, et al. The influence of gender in sepsis. Am J Respir Crit Care Med 2004; 169:A782.
30. Bauerle R, Rucker A, Schmandra TC, et al. Markov cohort simulation study reveals evidence for sex-based risk difference in intensive care unit patients. Am J Surg 2000; 179:207-211.
31. Schroder J, Kahlke V, Staubach KH, et al. Sex differences in human sepsis. Arch Surg 1998; 133:1200-1205.
32. Wichmann MW, Inthorn D, Andress HJ, et al. Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient sex on disease process and outcome. Intensive Care Med 2000; 26:167-172.
33. Crabtree TD, Pelletier SJ, Gleason TG, et al. Sex-dependent differences in outcome after the treatment of infection in hospitalized patients. J Am Med Assoc 1999; 282:2143-2148.
34. McLauchlan GJ, Anderson ID, Grant IS, Fearon KCH. Outcome of patients with abdominal sepsis treated in an intensive care unit. Br J Surg 1994;82:527-529.
35. The EPISEPSIS Study Group. EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 2004; 30:580-588.
36. Vincent J-L, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006; 34:344-353.
37. Bell J. The new genetics in clinical practice. Br Med J 1998; 316:618-620.
38. Collins FS. Shattuck lecture: medical and societal consequences of the Human Genome Project. N Engl J Med 1999; 341:28-37.
39. Guttmacher AE, Collins FS. Genomic medicine: a primer. N Engl J Med 2002;347:1512-1520.
40. Roeters van Lennep JE, Westerveld DW, Erkelens EE, van der Wall HT. Risk factors for coronary heart disease: implications of gender. Cardiovasc Res 2002; 53:538-549.
41. Neugarten J. Gender and the progression of renal disease. J Am Soc Nephrol 2002; 13:2807-2809.
42. Schwartz JB. The influence of sex on pharmacokinetics. Clin Pharmacokinet 2003; 42:107-121.
43. Lahita RG. Sex hormones and systemic lupus erythematosis. Rheum Dis Clin North Am 2000; 26:951-968.
44. Cutolo M, Sulli A, Seriolo B, et al. Estrogens, the immune response and autoimmunity. Clin Exp Rheumatol 1995; 13:217-226.
45. Verthelyi D. Sex hormones as immunomodulators in health and disease. Int Immunopharm 2001; 1:983-993.
46. Diodato MD, Knoferi MW, Schwacha MG, et al. Gender differences in the inflammatory response and survival following haemorrhage and subsequent sepsis. Cytokine 2001; 14:162-169.
47. Zellweger R, Wichmann MW, Ayala A, et al. Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males. Crit Care Med 1997; 25:106-110. (Pubitemid 27015048)
48. Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 1996;24:1125-1128.
49. Wichman MW, Zellweger R, DeMaso CM, et al. Gender differences: improved immune function in females as opposed to decreased immune function in males following hemorrhagic shock. Surg Forum 1995; 46:758-759.
50. Fiorentino DF, Zlotnik A, Mosmann TR, et al. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147:3815-3822.
51. Kahlke V, Dohm C, Mees T, et al. Gender related therapy: early interleukin-10 improves survival and enhances immune function only in males after hemorrhage and subsequent sepsis. Shock 2002; 18:24-28.
52. Greenberger MJ, Strieter RM, Kunkel SL, et al. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumoniae. J Immunol 1995; 155:722-729.
53. Standiford TJ, Strieter RM, Lukacs NW, Kunkel SL. Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J Immunol 1995; 155:2222-2229.
54. Hotchkiss R, Karl I. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138-150.
55. D'Agostino P, Milano S, Barbera C, et al. Sex hormones modulate inflammatory mediators produced by macrophages. Ann N Y Acad Sci 1999;876:426-429.
56. Trentzsch H, Stewart D, De Maio A. Genetic background conditions the effect of sex steroids on the inflammatory response during endotoxic shock. Crit Care Med 2003; 31:232-236.
57. Verthelyi D. Sex hormones as immunomodulators in health and disease. Int Pharmacol 2001; 1:983-993.
58. Tanriverdi F, Silveira LFG, MacColl GS, Bouloux PMG. The hypothalamicpituitary-gonadal axis: immune function and autoimmunity. J Endocrin 2003;176:293-304.
59. Viselli SM, Stanziale K, Shults WJ, et al. Castration alters peripheral immune function in normal male mice. Immunology 1995; 84:337-342.
60. Wichmann MW, Zellweger R, DeMaso CM, et al. Mechanism of immunosuppression in males following trauma-hemorrhage: critical role of testosterone. Arch Surg 1996; 131:1186-1192.
61. Angele MK, Wichmann MW, Ayala A, et al. Testosterone receptor blockade after hemorrhage in males: restoration of the depressed immune functions and improved survival following subsequent sepsis. Arch Surg 1997;132:1207-1214.
62. Walker SE, Besch-Williford CL, Keisler DH. Accelerated deaths from systemic lupus erythematosus in NZBxNZW F1 mice treated with the testosterone blocking-drug flutamide. J Lab Clin Med 1994; 124:401-407.
63. Nitsch SM, Wittmann F, Angele P, et al. Physiologic levels of 5-alhadihydrotestosterone depress wound immune function and impair wound healing following trauma hemorrhage. Arch Surg 2004; 139:157-163.
64. Wichmann MW, Ayala A, Chaudry IH. Male sex steroids are responsible for depressing macrophage immune function after trauma-hemorrhage. Am J Physiol 1997; 273:C1335-C1340.
65. Sorensen TI, Nielsen GG, Anderson PK, Teasdale TW. Genetic and environmental influences of premature death in adult adoptees. N Engl J Med 1988;318:727-732.
66. Mira JP, Cariou A, Grall F, et al. Association of TNF2, a TNF-a promoter polymorphism, with septic shock susceptibility and mortality. A multicenter study. J Am Med Assoc 1999; 282:561-568.
67. Tang G-J, Huang S-L, Yien H-W, et al. Tumor necrosis factor gene polymorphism and septic shock in surgical infection. Crit Care Med 2000;28:2733-2736.
68. Majetschak M, Flohe S, Obertacke U, et al. Relation of a TNF gene polymorphism to severe sepsis in trauma patients. Ann Surg 1999; 230:207-214.
69. Fang XM, Schroder S, Hoeft A, Stuber S. Comparison of two polymorphisms of the interleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis. Crit Care Med 1999;27:1330-1334.
70. Cohen J. The immunopathogenesis of sepsis. Nature 2002; 420:885-891.
71. Addison M, Dossett L, Norris P, et al. Estradiol is associated with mortality in critically ill trauma and surgical patients. Crit Care Med 2008; 36:62-68. Serum estradiol is a marker of injury severity and a predictor of death in the critically injured patient, regardless of sex. Whether or not estradiol plays a causal role in outcomes is unclear, but estrogen modulation represents a potential therapy for improving outcomes in critically ill trauma patients.
72. Hubacek JA, Stuber F, Frohlich D, et al. Gene variants of the bactericidal/ permeability increasing protein and lipopolysaccharide binding protein in sepsis patients: gender-specific genetic predisposition to sepsis. Crit Care Med 2001; 29:557-561.
73. Frost DW, Fowler RA. Factors influencing end-of-life decision-making by critically ill adult patients, surrogate decision-makers and healthcare professionals: a systematic review [abstract]. Am Thorac Soc 2009; A5237.
74. Hawker GA, Wright JG, Coyte PC, et al. Differences between men and women in the rate of use of hip and knee arthroplasty. N Engl J Med 2000;342:1016-1022.
75. Austin PC, Tu JV, Daly PA, Alter DA. The use of quantile regression in healthcare research: a case study examining gender differences in the timeliness of thrombolytic therapy. Stat Med 2005; 24:791-816.
76. García JA, Romano PS, Chan BK, et al. Sociodemographic factors and the assignment of do-not-resuscitate orders in patients with acute myocardial infarctions. Med Care 2000; 38:670-678.
77. Stolman CJ, Gregory JJ, Dunn D, Ripley B. Evaluation of the do not resuscitate orders at a community hospital. Arch Intern Med 1989; 149:1851-1856.
78. Zingmond DS, Wenger NS. Regional and institutional variation in the initiation of early do-not-resuscitate orders. Arch Intern Med 2005; 165:1705-1712.
79. Eachempati SR, Hydo L, Shou J, Barie PS. Sex differences in creation of donot-resuscitate orders for critically ill elderly patients following emergency surgery. J Trauma 2006; 60:193-197.
80. Cook DJ, Guyatt GH, Jaeschke R, et al. Determinants in Canadian healthcare workers of the decision to withdraw life support from the critically ill. Canadian Critical Care Trials Group. J Am Med Assoc 1995; 273:703-708.
81. Wenger NS, Pearson ML, Desmond KA, et al. Epidemiology of do-notresuscitate orders. Disparity by age, diagnosis, gender, race, and functional impairment. Arch Intern Med 1995; 155:2056-2062.
82. Goodlin SJ, Zhong Z, Lynn J, et al. Factors associated with use of cardiopulmonary resuscitation in seriously ill hospitalized adults. J Am Med Assoc 1999; 282:2333-2339.
83. Beach MC, Morrison RS. The effect of do-not-resuscitate orders on physician decision-making. J Am Geriatr Soc 2002; 50:2057-2061.
84. Barnato AE, Berhane Z, Weissfeld LA, et al., Robert Wood Johnson Foundation ICU End-of-Life Peer Group. Racial variation in end-of-life intensive care use: a race or hospital effect? Health Serv Res 2006; 41:2219-2237.
85. Marco CA, Schears RM. Societal opinions regarding CPR. Am J Emerg Med 2002; 20:207-211.
86. Nuckton TJ, List ND. Age as a factor in critical care unit admissions. Arch Intern Med 1995; 155:1087-1092.
87. Escher M, Perneger TV, Chevrolet JC. National questionnaire survey on what influences doctors' decisions about admission to intensive care. Br Med J 2004; 329:425.
88. Norris WM, Nielsen EL, Engelberg RA, Curtis JR. Treatment preferences for resuscitation and critical care among homeless persons. Chest 2005;127:2180-2187.
89. Van Scoy L, Sherman M. The effect of demographics, hospital course, and end of life preparedness on code status at time of death. Am J Respir Crit Care Med 2009; 179:A5225.
90. Van Spall HGC, Toren A, Kiss A, Fowler RA. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. J Am Med Assoc 2007; 297:1233-1240.
91. Lazongas C, Pinto RL, Ferguson ND, Fowler RA. Eligibility criteria in randomized clinical trials in the critical care literature. Am J Respir Crit Care Med 2008; 177:A41.
92. Vist GE, Hagen KB, Devereaux PJ, Oxman AD. Outcomes of patients who participate in randomized controlled trials versus those of similar patients who do not participate [Cochrane Library on CD-ROM]. Oxford, England: Update Software; 2001.
93. Davis S, Wright PW, Schulman SF, et al. Participants in prospective, randomized clinical trials for resected nonsmall cell lung cancer have improved survival compared with nonparticipants in such trials. Cancer 1985;56:1710-1718.
94. Schmidt B, Gillie P, Caco C, et al. Do sick newborns benefit from participation in a randomized clinical trial? J Pediatr 1999; 134:151-155.